Sunday, December 07, 2008

Stroke prevention in sickle cell anemia


STOP I demonstrated transfusions reduced stroke risk by 92 % in high risk children and TCD is used to select patients for transfusion. STOP II showed rising TCD velocities, especially above 200 cm/s cutoff, led to more strokes upon transfusion discontinuation.

Eleven percent stroke by age 20.
25 percent by age 45

Recommend at least annual TCD between ages 2-16

mortality with hemorrhage is 24-65 percent
Associations with hemorrhage: Hypertension, recent transfusion last 14 days, steroids, possibly NSIAA

nonatherosclerotic
point mutation valine for glu in Beta polypeptide chain

younger patients tend to get ischemic strokes, older patients hemorrhagic strokes, two thirds recur


No comments: